Cancer News and Research

Latest Cancer News and Research

Musical tones can reset the brain and effectively reduce insomnia

If you are among the 50 percent of Americans who suffer from insomnia, then you have probably tried everything – from warm milk to melatonin pills or prescription medications to induce sleep – with varying degrees of success and side effects. But what if sleep could be achieved not by a substance, but through 'balancing' brain activity?

21 Nov 2012

Scientists extract recent drug trials to tackle Alzheimer's earlier than ever before

Alzheimer's therapeutic trials have gotten bad press lately, but it is not all gloom and doom. As evident at the 5th Clinical Trials in Alzheimer's Disease (CTAD) conference, held 29-31 October in the Principality of Monaco, scientists keep extracting new data from recent drug trials to gear up for a round of new ones that aim to tackle Alzheimer's earlier than ever before.

21 Nov 2012

Certain mutated cells continue DNA replication process even after drug treatment

Certain mutated cells keep trying to replicate their DNA - with disastrous results - even after medications rob them of the raw materials to do so, according to new research from USC.

21 Nov 2012

UNC expert to talk about gratitude research at SPSP annual meeting, Jan. 17-19

Sara Algoe of the University of North Carolina-Chapel Hill who has investigated how gratitude benefits close relationships, including how expressing gratitude leads to long-term social outcomes for women with metastatic breast cancer and the evolutionary role for gratitude. She will be presenting some of this work at the SPSP annual meeting in New Orleans (Jan. 17-19, 2013), and she is a recipient of grant funding through the Expanding the Science and Practice of Gratitude project.

21 Nov 2012

Only 3% of patients actually receive stress management counseling: Study

While stress may be a factor in 60 to 80 percent of all visits to primary care physicians, only three percent of patients actually receive stress management counseling, say researchers at Beth Israel Deaconess Medical Center.

21 Nov 2012

Concord Medical third quarter 2012 total net revenues increase 65.2% to RMB206.1 million

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China and the parent of Chang'an Hospital, today reported its unaudited consolidated financial results for the third quarter ended September 30, 2012.

21 Nov 2012

Internet best method to communicate health messages to baby boomers

Communicating health information to the “baby boomer” generation might best be done via the internet, especially once they have hit 50, and then 65 years of age, suggest US researchers.

20 Nov 2012

Texas Biomed applies patent for new genetically-engineered vaccine strategy to prevent HIV

The Texas Biomedical Research Institute in San Antonio has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection that targets the outer layers of body structures that are the first sites of contact with the virus.

20 Nov 2012

Uninsured patients could be twice as likely to die after brain cancer surgery

Uninsured patients who undergo surgery to remove a brain tumor could be twice as likely to die in the hospital as those who have the same operation but are privately insured, new Johns Hopkins research suggests. In teaching hospitals, where most neurosurgical procedures take place, those with government-subsidized insurance in the form of Medicaid were found in the same study to have rates of survival closer to those who are privately insured.

20 Nov 2012

Scientists identify two genetic risk factors for sagittal craniosynostosis

Seattle Children's Research Institute, together with an international team of scientists and clinicians from 22 other institutions, have identified two genetic risk factors for the most common form of non-syndromic craniosynostosis, a birth defect in which the bony plates of an infant's skull prematurely fuse. The condition is known as sagittal craniosynostosis and often results in an abnormal head shape and facial features.

20 Nov 2012

Addition of tomosynthesis to standard mammogram increases breast screening accuracy

The addition of three-dimensional breast imaging-a technology called tomosynthesis-to standard digital mammography significantly increases radiologists' diagnostic accuracy while reducing false positive recall rates, according to the results of a multi-center study published in Radiology.

20 Nov 2012

New solar steam method from Rice University

Rice University scientists have unveiled a revolutionary new technology that uses nanoparticles to convert solar energy directly into steam. The new "solar steam" method from Rice's Laboratory for Nanophotonics (LANP) is so effective it can even produce steam from icy cold water.

20 Nov 2012

USPTO issues Notice of Allowance to Sanovas’ nested balloon catheter

Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's nested balloon catheter for localized drug delivery, a component of Sanovas' Vas Zeppelin Smart Catheter technology portfolio.

20 Nov 2012

Gifts That Give announces partnership with St. Jude Children's Research Hospital

Gifts That Give, Inc., the popular social commerce site with a strong charitable mission, announced its inaugural partnership with St. Jude Children's Research Hospital by joining the St. Jude Thanks and Giving campaign.

20 Nov 2012

Finnish researchers develop triumphant solution to predict breast cancer cells’ responses to drugs

The answer is yes. Finnish researchers have developed a triumphant solution for predicting responses of breast cancer cells to a set of cancer drugs. The prediction is based on the genomic profiles of the cancer cells. Harnessing genomic profiles of cells in choosing the best treatment is considered the holy grail of personalised medicine.

20 Nov 2012

Combination of perifosine and temsirolimus shows promise against malignant glioma

Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").

20 Nov 2012

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.

20 Nov 2012

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).

19 Nov 2012

Roundup: Wyo. conservatives ponder election; Ill. Insurer to buy Montana Blues; Calif. nurses plan new strike

But since the election, a blanket of baffled worry has descended on conservatives here like early snow across the plains, deepening a sense that traditional, rural and overwhelmingly white states in the center of the country are losing touch with an increasingly diverse and urban American electorate.

19 Nov 2012

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending approval of the oral, once-daily medication ZYTIGA for use in combination with prednisone or prednisolone in the treatment of metastatic castration-resistant prostate cancer (mCRPC), in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

19 Nov 2012

Cancer News and Research

Latest Cancer News and Research

Musical tones can reset the brain and effectively reduce insomnia

Scientists extract recent drug trials to tackle Alzheimer's earlier than ever before

Certain mutated cells continue DNA replication process even after drug treatment

UNC expert to talk about gratitude research at SPSP annual meeting, Jan. 17-19

Only 3% of patients actually receive stress management counseling: Study

Concord Medical third quarter 2012 total net revenues increase 65.2% to RMB206.1 million

Internet best method to communicate health messages to baby boomers

Texas Biomed applies patent for new genetically-engineered vaccine strategy to prevent HIV

Uninsured patients could be twice as likely to die after brain cancer surgery

Scientists identify two genetic risk factors for sagittal craniosynostosis

Addition of tomosynthesis to standard mammogram increases breast screening accuracy

New solar steam method from Rice University

USPTO issues Notice of Allowance to Sanovas’ nested balloon catheter

Gifts That Give announces partnership with St. Jude Children's Research Hospital

Finnish researchers develop triumphant solution to predict breast cancer cells’ responses to drugs

Combination of perifosine and temsirolimus shows promise against malignant glioma

Dune Medical Devices gets FDA PMA Approvable Letter for MarginProbe System

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Roundup: Wyo. conservatives ponder election; Ill. Insurer to buy Montana Blues; Calif. nurses plan new strike

Janssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC

Cancer Research - Second Edition eBook

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Newsletters you may be interested in